Development and Stability Indicating HPLC and LC-MS/MS Characterization of Force Degradation Products of Imeglimin Hydrochloride with Comparative In Silico Therapeutic and Toxicologial Profile
Computational Elucidation of Antidiabetic Herb Mechanism: A Proposal Using In-silico Tools
HPLC PDA and LC-MS/MS study for Vadadustat Degradants with Comparative In-silico Therapeutic and Toxicological Profiling to Assist Future Drug Delivery
In Silico Identification and Evaluation of Marine-Derived Phytochemicals with Potential Anti-Alzheimer Properties
Phytochemical Investigation Of Ancient Baobab Tree (Adansonia Digitata) Endowed with Promising Anti -Oxidant and Anti-Cancer Activity
Development of Stability Indicating HPLC and LC-MS/MS Compatible Method for Characterization of Forced Degradation Products of Mavacamten
Investigation of New 3,5-Diaryl Substitued Pyridine and Pyrazine Derivatives as Potential Anticancer Agents
Analytical Profiling of Vibegron Drug Substance and Product Using LC-MS /MS
Anti - Hypertensive Activity of Garcinia Indica Fruit Rind on Cadmium Chloride Induced Hypertensive Rats
Prognostic Study of Hyperhomocysteinemia on PTZ Induced Kindling Seizures
Exploring the Neuroprotective Potential of Bovine Colostrum and L-Borneol in Alzheimer's Disease
Evaluation of Geraniol Against PTZ Induced Kindling in Rats
Role of Garcinia Indica Fruit Rind on Diabetic Cardiomyopathy
The Role of Glutathione and Selenium in Management of Alzheimer's Disease
Evaluating the Hepatoprotective Effects of Haematococcus Pluvialis and Silybum Marianum Extract
Exploring the Effect of Lobeglitazone in Neuroinflammatory Pathway of Alzheimer's Disease
"Part I - Eurasian Economic Union: Analyzing Drug Registration Pathways, Dossier Requirements and Comparison with European Union's Regulatory Frameworks Part II - Implementation of Regulatory Practices for Pharmaceutical Submission in the European Union"
"Part I - Regulatory Framework for the Novel Polymers and Features of Approved Polymers in Orally Disintegrating Tablets as per U.S. FDA Part II - Preparation of Module 3 for the Submission of ANDA in the U.S. Market at Bliss GVS Pharma Ltd"
"Part I - Regulatory Framework for Coronary Stents in Regulated and Semi- Regulated Countries. Part II - Understanding Regulatory Submissions: Ensuring Global Regulatory Compliance"
"Part I - Regulatory Compliance Leveraging Artificial Intelligence - A comprehensive Study of Opportunities and Challenges Part II - From Analytical Profiling to Regulatory Affairs - Stability, Assessment, Forced Degradation and RA Submissions for Emerging Markets "